Is Thymosin Beta‑4 a real game‑changer for heart recovery?

Posted by greg208 in Research & News - 2 points, 0 comments.

I came across a 2023 paper in the Journal of Molecular Medicine that looked at TB‑4 in mice after a heart attack. The authors saw a boost in ejection fraction and less scar tissue after eight weeks of 1‑2 mg injections. It’s not a human trial but the numbers are eye‑catching, and the mechanism – actin sequestration and angiogenesis – makes sense.

I’ve been using TB‑4 3x a week for 12 weeks to help my knee recover after marathon training, and I’ve noticed less swelling and a quicker return to full range of motion. I’m curious whether the same approach could help people with cardiac injury. com/peptides/thymosin-beta-4) shows similar doses but a slightly shorter half‑life.

Anyone here has any clinical data, long‑term safety insights, or thoughts on whether TB‑500 offers a benefit over(before?) the full‑length peptide?

Community discussion - research and educational context only. Not medical advice.